Clinical Trial Update: Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating glucagon dose-response in patients with post-bariatric hypoglycemia; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Post-bariatric Hypoglycemia
• Reactive Hypoglycemia

Drugs mentioned

• GLUCAGON (GLUCAGON)

Snippet

Sponsor: Joslin Diabetes Center | Conditions: Hypoglycemia, Hypoglycemia, Reactive | Phase 4 | Status: ACTIVE_NOT_RECRUITING